Antiviral Activity of Carrageenans and Processing Implications.

Mar Drugs · 2021 · PMC8400836 · PMID 34436276

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

From a recent compilation of safety profiles for different types of carrageenans in subclinical assays with different cells and in clinical studies [ 32 ], half maximum cytotoxicity concentrations were in the range 5–3000 μg/mL with a slight trend showing lower toxicity for the more sulfated carrageenans.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.